Work

Abstract 882: Soluble TNF blockade enhances trastuzumab-deruxtecan innate antitumor immune response and type-I IFN signalling in HER2-positive breast cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-882

Authors: Sofia Bruni, Camila Jencquel, Martin A. Rivas, Roxana Schillaci, Maria F. Mercogliano

Institutions: University of Miami, Experimental Medicine and Biology Institute

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409690674

Cites:

Cited by:

Related to: 10